Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration helps transgender patients achieve desired gender appearances.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Progesterone may help trans women with breast development and health, but more research is needed.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Testosterone treatment may affect heart response to stress in transgender men.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Women have smaller foreheads and different hairline shapes than men.